Piperazines
Piperazines are six-membered ring compounds with two nitrogen atoms. They are significant in the development of pharmaceuticals, particularly as central nervous system agents, and are also used in organic synthesis. At CymitQuimica, we provide a wide range of high-quality piperazines to support your research and industrial applications.
Subcategories of "Piperazines"
Products of "Piperazines"
4-Benzhydryl-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)piperazine-1-carboxamide
Ref: 10-F729087
1g | Discontinued | Request information |
Ref: 10-F612287
1g | Discontinued | Request information |
Ref: 10-F365241
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information |
4-Bromo-2-(4-Boc-piperazinomethyl)-1-fluorobenzene
Ref: 10-F638647
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information |
2-(4-(2,2,2-Trifluoroethyl)piperazin-1-yl)propanoic acid
Ref: 10-F733633
1g | Discontinued | Request information | |
2g | Discontinued | Request information | |
5g | Discontinued | Request information |
2-Methyl-1-(3-(piperazin-1-yl)azetidin-1-yl)propan-1-one
Ref: 10-F682069
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
Ref: 10-F675991
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
2-Methyl-3-(4-methylpiperazin-1-yl)propan-1-amine
Ref: 10-F664197
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
(4-Benzoylpiperazin-1-yl)(3-chlorophenyl)methanone
Ref: 10-F706652
1g | Discontinued | Request information |
4-Methyl-N-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)benzenesulfonamide
Ref: 10-F756659
1g | Discontinued | Request information |
2-[1-(chloroacetyl)-3-oxopiperazin-2-yl]-N-(4-methylphenyl)acetamide
Ref: 10-F371581
1g | Discontinued | Request information | |
5g | Discontinued | Request information |
2-(3-Chlorophenyl)-5-methyl-4-(piperazin-1-ylmethyl)oxazole
Ref: 10-F755106
1g | Discontinued | Request information |
3-Bromo-4-[(4-methylpiperazin-1-yl)methyl]aniline
Ref: 10-F654443
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
1-((4h-1,2,4-Triazol-3-yl)methyl)piperazine dihydrochloride
Ref: 10-F676450
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
250mg | Discontinued | Request information |
2-(3-Methylphenyl)-2-(piperazin-1-yl)ethan-1-ol
Ref: 10-F672424
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
2-Chloro-1-(4-(pyridin-2-yl)piperazin-1-yl)propan-1-one
Ref: 10-F684049
1g | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
4-(2-Chloro-thiazol-5-ylmethyl)-piperazine-1,3-dicarboxylic acid 1-tert-butyl ester
Ref: 10-F090647
500mg | Discontinued | Request information |
3-(4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)propanoic acid
Ref: 10-F732026
1g | Discontinued | Request information | |
5g | Discontinued | Request information |
Ref: 10-F090368
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |
1-[1-(3-ethyl-1,2,4-oxadiazol-5-yl)ethyl]piperazine
Ref: 10-F670739
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |